Queensland life sciences
directory

The University of Queensland is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.UQ is consistently ranked among the world's top 50 universities. In the 2022 Aggregate Ranking of Top Universities, UQ ranked 2nd in Australia and 42nd in the world.

A young, fresh university driven by an unwavering belief that community and culture is just as important as a world-class education, delivered by world-class educators. We may not be the biggest university, but we’re growing fast, and doing big things. Like ground-breaking research, championing sustainability, producing gold-winning athletes and award-winning alumni. Our first campus, on the Sun

The University of Southern Queensland (USQ) is a young, dynamic university. USQ has campuses in the regional centres of Toowoomba, Springfield and Ipswich. USQ is internationally recognised for delivering practical, world-class research that delivers high-impact solutions.

The UltraThera is a non-invasive, incisionless, and radiation-free medical device developed by researchers at The University of Queensland's Queensland Brain Institute. It uses low-frequency transcranial scanning ultrasound to treat brain diseases like Alzheimer's. By overcoming the blood-brain barrier, it enables a multi-modal therapeutic approach to address treatment limitations and facilitate the development of effective treatments.

UniQuest is Australia’s leading commercialisation entity, specialising in commercialising the intellectual property of The University of Queensland, a global top 50 university. Uniquest benchmarks in the top tier of technology transfer worldwide.

Uniseed is Australia’s longest running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and a leading Australian Superannuation Fund, UniSuper. These research organisations collectively spend $4 billion on research annually, making up over 40% of the total research spend in all research organisations in Australia.

USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.

Urmi Quality Management Consulting (UQMC) help life science organizations establish compliant and phase-appropriate quality systems that adapt to the changing needs of the business. Combining knowledge and experience from both the Pharmaceutical and ISO 9001 Quality Management System, UQMC consultants assist life science start-ups, CDMOs, commercial manufacturers and supporting industries in adopting quality system elements that enable leaner, compliant and robust operations.

VALD Performance is a world leader in musculoskeletal assessment and rehabilitation technologies. VALD technologies are used by over 1,000 of the world’s most elite sports organisations, clinics, universities, hospitals and defence departments to measure human movement, performance and injury rehabilitation.

VFV is a fluid technology company providing fluid handling solutions in life sciences and design.

Vast Bioscience is a privately owned biotechnology company established to exploit a proprietary technology platform called VAST (Versatile Assembly on Stable Templates). Vast offers the pharmaceutical industry a unique opportunity to develop innovative drugs with superior potency, target selectivity and safety.

Vaxxas is commercialising novel technology that dramatically enhances the performance of existing next-generational vaccines. Their delivery platform enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the skin’s surface. Vaxxas’ proprietary Nanopatch™ technology aims to provide an optimised, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.

Led by Director and Founder Dr. Patrick Silvey a specialist in Innovation Project design and scoping, VenturePro supports companies, government agencies, not-for-profits, and research organisations to become investment-ready. Dr. Silvey channels the talent and passion of VenturePro’s clients to turn discoveries and ideas into market-ready solutions or evidence-based policies for a better world. Over 18 years VenturePro has helped secure over $2.05 billion in funding for both short and long-term innovation projects and high-growth ventures.

ViceBio were founded to develop the patented Molecular Clamp technology invented at The University of Queensland, Australia and exclusively licensed to Vicebio by UniQuest, the commercialisation company of UQ. The Molecular Clamp technology stabilises viral glycoproteins in “prefusion” conformation, to deliver highly protective and ready-to-use fully liquid vaccines.

WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.

Established in 1994 by a group of dedicated doctors, Wesley Research Institute is Queensland’s second-oldest medical research institute. Wesley Research Institute aims to improve patient outcomes by linking medical and health research to clinical outcomes.

West is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world’s top pharmaceutical and biotechnology companies—working by their side to improve patient health.

Women in Technology (WiT) is one of Australia’s biggest communities that support women in across all fields of science and technology. As a not-for-profit organisation, we exist solely to create opportunities for our members and provide a dynamic platform to empower women from all disciplines to unlock their career potential. For more than two decades we have helped women find the inspiration and support they need to achieve their aspirations and, in doing so, we are helping our community take full advantage of the outstanding talent, energy and capacity they bring to our emerging digital economy.

Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020.